Literature DB >> 6247371

Evaluation of the analgesic properties of zomepirac.

T P Pruss, J F Gardocki, R J Taylor, L D Muschek.   

Abstract

Zomepirac, an inhibitor of prostaglandin biosynthesis, was evaluated for analgesic activity in a number of pharmacological screens. In the acetylcholine writhing test, zomepirac was found to be more potent than codeine, pentazocine, aspirin, and acetaminophen and equivalent in potency to morphine. Zomepirac was inactive in a number of tests that detect narcotic agents, suggesting that the drug will not induce physical dependence. The possibility of a central nonnarcotic as well as a peripheral analgesic mechanism merits consideration.

Entities:  

Mesh:

Substances:

Year:  1980        PMID: 6247371     DOI: 10.1002/j.1552-4604.1980.tb01701.x

Source DB:  PubMed          Journal:  J Clin Pharmacol        ISSN: 0091-2700            Impact factor:   3.126


  6 in total

Review 1.  Variability in response to NSAIDs. Fact or fiction?

Authors:  R O Day; G G Graham; K M Williams; P M Brooks
Journal:  Drugs       Date:  1988-12       Impact factor: 9.546

Review 2.  The antialgesic drugs: human therapeutic correlates of their potency in laboratory animal models of hyperalgesia.

Authors:  B Dubinsky; S Gebre-Mariam; R J Capetola; M E Rosenthale
Journal:  Agents Actions       Date:  1987-02

3.  The antinociceptive activity of paracetamol in zymosan-induced peritonitis in mice: the role of prostacyclin and reactive oxygen species.

Authors:  N S Doherty; T H Beaver; K Y Chan; R J Dinerstein; K A Diekema
Journal:  Br J Pharmacol       Date:  1990-12       Impact factor: 8.739

Review 4.  Zomepirac: a review of its pharmacological properties and analgesic efficacy.

Authors:  P A Morley; R N Brogden; A A Carmine; R C Heel; T M Speight; G S Avery
Journal:  Drugs       Date:  1982-04       Impact factor: 9.546

Review 5.  Non-steroidal anti-inflammatory analgesics other than salicylates.

Authors:  R N Brogden
Journal:  Drugs       Date:  1986       Impact factor: 9.546

Review 6.  The problems and pitfalls of NSAID therapy in the elderly (Part II).

Authors:  A G Johnson; R O Day
Journal:  Drugs Aging       Date:  1991-05       Impact factor: 3.923

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.